Poland· PL-100060306

Scopolan

A butylscopolamine product containing hyoscini butylbromidum, registered in Poland by Wrocławskie Zakłady Zielarskie "Herbapol" S.A.. The same ATC class is registered in 11 of our 19 countries.

ATC A03BB01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedScopolanATCA03BB01REGISTER NO.PL-100060306PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Butylscopolamine is registered in 11 of 19 countries.

Countries holding a registration under ATC A03BB01 (butylscopolamine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Butylscopolamine · ATC A03BB01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Hyoscini butylbromidum
Manufacturer
Wrocławskie Zakłady Zielarskie "Herbapol" S.A.
Country
Poland (PL)
ATC code
A03BB01
ATC class
Butylscopolamine
Defined daily dose
60 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990336319

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f5e893da-53bb-4021-84ee-6292b0c98caa
GET /v1/drugs/f5e893da-53bb-4021-84ee-6292b0c98caa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Czopki",
  "source": "urpl",
  "strength": "10 mg",
  "packaging": "05909990336319 ¦ OTC ¦ 17405\n6 szt.",
  "substance": "Hyoscini butylbromidum 0.01 mg",
  "common_name": "Hyoscini butylbromidum",
  "pl_product_id": "100060306",
  "pozwolenie_nr": "03363",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about butylscopolamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.